Jane Street’s Inovio Pharmaceuticals INO Stock Holding History

Jane Street’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-40,800	Closed	-$71K	–	12316
2026 Q1	$71K	Buy	+40,800	New	+$67.2K	﹤0.01%	10814
2023 Q1	–	Sell	-2,950	Closed	-$55.2K	–	9446
2022 Q4	$55.2K	Sell	2,950 -1,583	-35%	-$35.9K	﹤0.01%	8331
2022 Q3	$94K	Buy	4,533 +2,775	+158%	+$71K	﹤0.01%	8675
2022 Q2	$37K	Sell	1,758 -10,775	-86%	-$304K	﹤0.01%	9000
2022 Q1	$540K	Sell	12,533 -6,234	-33%	-$281K	﹤0.01%	7326
2021 Q4	$1.12M	Buy	18,767 +2,842	+18%	+$228K	﹤0.01%	5657
2021 Q3	$1.37M	Sell	15,925 -242	-1%	-$24.3K	﹤0.01%	5280
2021 Q2	$1.8M	Sell	16,167 -37,266	-70%	-$3.58M	﹤0.01%	4526
2021 Q1	$5.95M	Sell	53,433 -3,092	-5%	-$407K	﹤0.01%	2155
2020 Q4	$6M	Sell	56,525 -12,292	-18%	-$1.64M	﹤0.01%	1919
2020 Q3	$9.58M	Sell	68,817 -75,700	-52%	-$15.8M	0.01%	1245
2020 Q2	$46.7M	Buy	144,517 +114,575	+383%	+$18.4M	0.04%	384
2020 Q1	$2.67M	Buy	+29,942	New	+$1.85M	﹤0.01%	1725

Other funds holding INO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jane Street's INO Position: Q2 2026 in Review

Jane Street increased its Inovio Pharmaceuticals (INO) stake by 306% in Q2 2026, buying an estimated $111K and bringing the position to 124,525 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #10413.

Jane Street first reported a position in INO in Q4 2013 and has held it in 38 quarters since. The position peaked at $23.3M in Q2 2020. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

Jane Street held 124,525 shares of Inovio Pharmaceuticals worth $137K as of Q2 2026.
Jane Street bought 93,834 Inovio Pharmaceuticals shares in Q2 2026, an estimated $111K.
Inovio Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10413 holding.
Jane Street first reported a position in Inovio Pharmaceuticals in Q4 2013 and has held it in 38 quarters since.
Jane Street's Inovio Pharmaceuticals position peaked at $23.3M in Q2 2020.
102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.